Oxidative eustress is associated with AMPK and AKT activation, GLUT4 translocation and glucose uptake in skeletal muscle cells and fibres Authors: Eva Martín-Prieto, Leonardo A. Catalano-Iniesta, Escarlata Fernández-Puente, Jesús Palomero Published: 2026 ABSTRACT Abstract Objectives: Reactive oxygen and nitrogen species (RONS) act as signalling molecules under physiological conditions; however, how oxidative eustress regulates glucose uptake in skeletal muscle remains poorly defined. We investigated the role of moderate oxidation in skeletal muscle glucose uptake, focusing on AKT/AMPK phosphorylation, GLUT4 translocation and functional glucose uptake. Methods: AKT and AMPK phosphorylation were analysed in C2C12 myoblasts/myotubes exposed to insulin and redox-modulating stimuli associated with oxidative eustress, including hydrogen peroxide, nitric oxide donors and angiotensin II. GLUT4 translocation was assessed by quantitative immunocytochemistry and confocal fluorescence microscopy in cells expressing a GLUT4 reporter. Glucose uptake was evaluated in isolated skeletal muscle fibres using 6-NBDG. Results: Oxidative eustress was associated with increased AKT and AMPK phosphorylation and enhanced GLUT4 translocation to the plasma membrane. Hydrogen peroxide, nitric oxide donors and angiotensin II increased GLUT4 presence at the plasma membrane and enhanced glucose uptake, with hydrogen peroxide showing a dose-dependent effect. Increased glucose uptake was consistent with GLUT4 translocation. Discussion: These findings support oxidative eustress as a physiological redox mechanism linking AKT/AMPK activation, GLUT4 translocation and glucose uptake in skeletal muscle. Redox signalling may therefore contribute to skeletal muscle glucose metabolism. Introduction From a historical perspective, free radicals and reactive oxygen and nitrogen species (RONS) have been considered molecules responsible for cellular oxidative damage when present at high concentrations. Their interaction with cellular macromolecules such as proteins, lipids, nucleic acids and carbohydrates produces irreversible oxidative modifications that lead to cellular dysfunction. This classical phenomenon is known as ‘oxidative stress’, currently referred to as ‘oxidative distress’ [1–3]. During the last two decades, numerous studies have demonstrated that RONS are also important regulators of cellular signalling when present at low concentrations, a concept now defined as ‘oxidative eustress’. Under physiological conditions, low and tightly controlled levels of RONS act as secondary messengers that modulate signalling pathways through reversible redox modifications, thereby influencing cellular function and adaptation. This paradigm shift has led to the distinction between oxidative distress, associated with excessive and damaging RONS accumulation, and oxidative eustress, in which moderate RONS levels promote signalling responses and cellular homoeostasis [4,5]. Among RONS, hydrogen peroxide (H₂O₂) and nitric oxide (NO) have emerged as key redox signalling molecules. Hydrogen peroxide is relatively stable and diffusible, and it modulates the activity of kinases, phosphatases and transcription factors [4,6]. Substantial evidence supports a role for H₂O₂ as a central mediator of signal transduction in multiple biological contexts, although accurately quantifying its spatiotemporal dynamics remains technically challenging [7–9]. Nitric oxide also regulates diverse physiological processes through interactions with intracellular targets and post-translational modifications, and it has been implicated in the modulation of metabolic signalling pathways. Importantly, the balance between reactive oxygen and nitrogen species is critical, as excessive superoxide production may lead to the formation of highly reactive species such as peroxynitrite, disrupting redox homoeostasis and contributing to pathological states [10,11]. Redox signalling has been increasingly recognised as a crucial regulator of cellular metabolism, including glucose handling and energy homoeostasis. Accumulating evidence indicates that RONS participate in the regulation of glucose uptake and insulin signalling, acting either as facilitators of physiological responses or as contributors to metabolic dysfunction when present at excessive levels [12–14]. In this context, oxidative eustress has been proposed as a mechanism by which moderate RONS levels enhance metabolic flexibility and adaptive responses, whereas redox imbalance and oxidative distress are associated with insulin resistance, ageing and metabolic disease [15]. However, how defined redox signals regulate GLUT4 translocation and functional glucose uptake in skeletal muscle remains incompletely understood. Glucose is a fundamental substrate for cellular metabolism, and skeletal muscle plays a central role in whole-body glucose disposal and glycaemic control. As glucose cannot freely diffuse across the plasma membrane, its uptake requires glucose transporters (GLUTs), with GLUT4 being the predominant isoform expressed in skeletal muscle [16]. The translocation of GLUT4 from intracellular compartments to the plasma membrane is therefore essential for the maintenance of glucose homoeostasis. Both insulin and contractile activity stimulate glucose uptake by promoting GLUT4 translocation; however, the signalling mechanisms governing this process remain incompletely defined [15,17,18]. During dynamic exercise, glucose uptake by skeletal muscle can increase up to fifty-fold relative to basal levels. This response depends on glucose availability, membrane transport and intracellular metabolism, and is regulated by local factors such as reactive oxygen and nitrogen species, nitric oxide, calcium (Ca2+), calmodulin-dependent kinases (CaMK) and AMP-activated protein kinase (AMPK) [19–22]. Insulin similarly promotes GLUT4 translocation, and accumulating evidence indicates that signalling pathways regulated by RONS also participate in this process. However, the specific contribution of oxidative eustress to GLUT4 translocation and functional glucose uptake in skeletal muscle remains to be fully elucidated. In this context, hydrogen peroxide generation in skeletal muscle has been directly associated with increased glucose uptake in isolated preparations, and H₂O₂ appears to stimulate glucose transport through mechanisms that only partially overlap with canonical insulin signalling pathways [4,21,23]. Thus, ROS, particularly H₂O₂, together with RNS such as NO, emerge as important regulators of glucose transport during exercise and contractile activity. Our recent work and that of others support the concept that moderate levels of RONS, defined as oxidative eustress, may activate key signalling pathways such as AKT and AMPK, thereby promoting GLUT4 translocation and facilitating glucose uptake [15,21,22,24]. A better understanding of these redox-dependent mechanisms is required to determine whether ROS and RNS contribute to normal insulin signalling and glucose transport, whether dysregulation of these processes participates in pathological conditions such as insulin resistance, obesity or ageing, and whether components of this redox-regulated system may represent potential pharmacological targets for therapeutic intervention [21,25,26]. Despite the increasing recognition of reactive oxygen and nitrogen species as key modulators of cellular signalling, important gaps remain in our understanding of how redox signalling regulates glucose uptake in skeletal muscle under physiological conditions. Although hydrogen peroxide and nitric oxide have been implicated in the control of glucose transport, the specific signalling pathways involved, the degree of oxidation required to elicit a physiological response, and the relationship between redox signalling, GLUT4 translocation and functional glucose uptake remain incompletely defined [16]. Based on current evidence and our previous findings, we hypothesised that moderate levels of reactive oxygen and nitrogen species, specifically hydrogen peroxide and nitric oxide, acting within an oxidative eustress range, facilitate glucose uptake in skeletal muscle. We further proposed that this effect is associated with the activation of redox-sensitive signalling pathways, including AKT and AMPK, and with increased translocation of GLUT4 to the plasma membrane. Therefore, the aim of the present study was to investigate the role of oxidative eustress in the regulation of skeletal muscle glucose uptake by analysing the activation of AKT and AMPK signalling pathways, the translocation of GLUT4, and the functional uptake of glucose. To address this, we employed complementary experimental approaches using C2C12 myoblasts/myotubes and isolated mature skeletal muscle fibres. Material and methods Reagents The following reagents were used at the concentrations indicated for each experimental intervention: Hydrogen peroxide solution 30% (v/v) (Sigma-Aldrich, Cat. No. H1009), S-nitroso-N-acetyl-DL-penicillamine (SNAP) (Sigma-Aldrich, Cat. No. N3398), sodium nitroprusside (SNP) (Sigma-Aldrich, Cat. No. 71778), diamide (Merck, Cat. No. D3648), angiotensin II (Sigma-Aldrich, Cat. No. A9525), and recombinant human insulin (Merck, Cat. No. 91077C). Recombinant human insulin was supplied as a lyophilised powder and reconstituted according to the manufacturer’s instructions to obtain the appropriate working concentrations. All reagents were of analytical grade. Stock solutions were prepared following the manufacturer’s recommendations and diluted in the corresponding experimental media immediately before use. C2C12 skeletal muscle cell culture and differentiation C2C12 mouse skeletal muscle myoblasts (CRL-1772, ATCC) were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) (Sigma-Aldrich, Cat. No. D5671) supplemented with 10% v/v foetal bovine serum (FBS) (Sigma-Aldrich, Cat. No. F9665), 2 mM L-glutamine (Gibco, Cat. No. 25030-024), 50 IU/mL penicillin and 50 μg/mL streptomycin (Gibco, Cat. No. 15140-122). Cells were maintained at 37 °C in a humidified atmosphere with 5% CO₂. For differentiation, myoblasts were grown to 80–90% confluence and the growth medium was replaced with differentiation medium consisting of DMEM supplemented with 2% v/v horse serum (Gibco, Cat. No. 26050-070) and antibiotics. Cells were maintained in differentiation medium for 6–7 days until formation of multinucleated myotubes. Animals Female C57BL/6J mice (4–5 months old; n = 9 animals) were used for isolation of skeletal muscle fibres. Female mice of the same strain and age range were used to reduce biological variability in this exploratory ex vivo study and to obtain representative single-fibre-level data while minimising animal use in accordance with the 3 R principles. All procedures were approved by the Bioethics Committee of the University of Salamanca (approval Nº 289) and authorised by the Junta de Castilla y León - Consejería de Agricultura y Ganadería on 3 August 2018. All procedures were performed in accordance with Spanish legislation, including RD 53/2013, as subsequently amended by RD 1083/2025, and European Union Directive 2010/63/EU on the protection of animals used for scientific purposes. Animals were euthanized by cervical dislocation in accordance with the approved ethical procedures, and both flexor digitorum brevis (FDB) muscles were subsequently dissected from each animal for the isolation of single skeletal muscle fibres. Isolation of single skeletal muscle fibres Single skeletal muscle fibres were isolated from the flexor digitorum brevis muscle as previously described with minor modifications [27,28]. Briefly, FDB muscles were excised and incubated in collagenase type I from Clostridium histolyticum (Sigma-Aldrich, Cat. No. C0130) 0.4% w/v prepared in Minimum Essential Medium (MEM) (Sigma-Aldrich, Cat. No. M8042) supplemented with 10% v/v foetal bovine serum, 2 mM L-glutamine, 50 IU/mL penicillin and 50 μg/mL streptomycin. Muscles were digested at 37 °C for 2 h with gentle agitation every 30 min to facilitate dissociation of connective tissue. Following enzymatic digestion, muscle bundles were gently triturated using a wide-bore pipette to release single intact fibres. Fibres were separated from debris and damaged fibres by low-speed centrifugation (600 × g, 30 s) and washed four times in fresh culture medium. Cleaned fibres were plated onto Matrigel (Corning, Cat. No. 356237) coated dishes and maintained in MEM at 37 °C in a humidified atmosphere containing 5% CO₂. Experiments were performed 24–48 h after isolation. Only morphologically intact fibres without visible signs of contracture or membrane disruption were selected for experimentation. Each individual fibre was considered an experimental observation for fluorescence analysis and is represented as an individual data point in the graphs shown in Figure 5. GLUT4-7myc-GFP plasmid preparation The GLUT4-7myc-GFP plasmid (Addgene, Cat. No. 52872) was amplified in Escherichia coli DH5α competent cells (Invitrogen, Cat. No. 11583117) and purified using a commercial plasmid purification kit (Thermo Fisher Scientific, Cat. No. K0482) according to the manufacturer’s instructions. Plasmid DNA concentration and purity were determined spectrophotometrically using a NanoDrop instrument (Thermo Scientific). Plasmid integrity was further verified by restriction enzyme digestion followed by agarose gel electrophoresis to confirm the expected fragment size. Purified plasmid DNA was stored at −20 °C until use. Transfection of C2C12 myoblasts and differentiation into myotubes C2C12 myoblasts at 70–80% confluence were transfected with GLUT4-7myc-GFP plasmid using a polymer-based transfection reagent (TransIT-X2) (Mirus Bio, Cat. No. MIR 6003) following the manufacturer’s protocol with optimisation in our laboratory. After 24 h, growth medium was replaced with differentiation medium, and cells were maintained for 6 days to allow formation of transfected myotubes. Expression of the GLUT4 reporter was verified by fluorescence microscopy prior to experiments. Quantitative immunoblotting for AKT and AMPK phosphorylation Protein extracts from C2C12 myoblasts/myotubes or isolated skeletal muscle fibres were prepared in lysis buffer containing 10 mM Tris–HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% (v/v) Triton X-100, 10% (v/v) glycerol, 0.1% (w/v) sodium dodecyl sulphate (SDS), 0.5% (w/v) deoxycholate, and protease inhibitors (Sigma-Aldrich, Cat. No. P8340). Total protein concentration was determined using a bicinchoninic acid (BCA) assay (Sigma-Aldrich, Cat. No. BCA1). Equal amounts of protein (30 μg) were resolved by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were blocked and incubated overnight at 4 °C with primary antibodies against phosphorylated AMPK (Thr172; rabbit anti-phospho-AMPK, Invitrogen, Cat. No. PA5-37821, dilution 1:1000), total AMPK (mouse anti-AMPK, Invitrogen, Cat. No. AH01332, dilution 1:500), phosphorylated AKT (Ser473; mouse anti-phospho-AKT, ProteinTech, Cat. No. 66444-1-Ig, dilution 1:1000), total AKT (rabbit anti-AKT, Cell Signalling Technology, Cat. No. 9272, dilution 1:500), and actin-rhodamine (Bio-Rad, Cat. No. 12004163, dilution 1:1000). Fluorescent secondary antibodies emitting at 520 nm (Anti-rabbit SB 520 nm, Bio-Rad, Cat. No. 12005870, dilution 1:2500 and Anti-mouse SB 520 nm, Bio-Rad, Cat. No. 12005860, dilution 1:2500) and 700 nm (Anti-rabbit SB 700 nm, Bio-Rad, Cat. No. 12004162, dilution 1:2500 and Anti-mouse SB 700 nm, Bio-Rad, Cat. No. 12004159, dilution 1:2500) were used for detection, allowing simultaneous visualisation of phosphorylated and total proteins within the same membrane. Membranes were imaged using a fluorescence-based imaging system. Fluorescence acquisition was performed within the linear dynamic range of the detection system to avoid signal saturation. Band intensities were quantified using imaging software. Phosphorylation levels were expressed as the ratio of phosphorylated protein to total protein for each sample after normalisation to actin. Detailed quantification procedures are provided in the Supplementary Methods. Immunocytochemistry and quantitative analysis of GLUT4 translocation Transfected C2C12 myotubes expressing GLUT4-7myc-GFP were incubated in Krebs solution containing 119 mM NaCl, 2.5 mM KCl, 2.5 mM CaCl₂·2H₂O, 1.5 mM MgSO₄·7H₂O, 1.25 mM NaH₂PO₄, 26.2 mM NaHCO₃ and 11.1 mM glucose, pH 7.4, prior to treatments. Following exposure to experimental stimuli, cells were fixed with 4% w/v paraformaldehyde (Sigma-Aldrich, Cat. No. P6148) and blocked with bovine serum albumin (BSA) (Sigma-Aldrich, Cat. No. A7906). Surface-exposed GLUT4 was detected using an anti-Myc primary antibody (Anti-Myc tag mouse, Abcam, Cat. No. [9E10] ab32, dilution 1:200) and an Alexa Fluor 568-conjugated secondary antibody (Anti-mouse Alexa Fluor 568, Invitrogen, Cat. No. A11031, dilution 1:1000). Fluorescence images were acquired under identical settings within each experiment. Quantitative analysis was performed by selecting regions of interest (ROI) corresponding to individual myotubes. Net fluorescence was calculated by subtracting background fluorescence. The GLUT4 translocation ratio was determined as the fluorescence intensity from the surface (red channel) normalised to total GLUT4-GFP fluorescence (green channel), expressed as a percentage. GLUT4 translocation analysis was performed only in GFP-positive C2C12 myotubes expressing the GLUT4-7myc-GFP reporter. Untransfected myotubes were excluded from the analysis. For each selected myotube, surface-exposed GLUT4 detected by anti-c-Myc immunostaining was normalised to total GLUT4-GFP fluorescence measured in the same cell. Therefore, the quantification was performed at the level of individual reporter-positive myotubes and did not depend on the overall transfection efficiency of the culture. 6-NBDG glucose uptake assay in isolated skeletal muscle fibres Glucose uptake was assessed using the fluorescent glucose analogue 6-NBDG (20 µM, Invitrogen, Cat. No. N23106). Isolated FDB fibres were incubated in the same Krebs solution described above, and baseline fluorescence images were recorded. Fibres were then exposed to 6-NBDG in the presence or absence of experimental treatments for 60 min at 37 °C. After incubation, fibres were washed and fluorescence images were acquired from the same regions when possible. Baseline and post-incubation measurements were obtained from the same fibre whenever possible. Fluorescence intensity was quantified by ROI analysis with background subtraction. The mean fluorescence intensity measured before incubation was used as a reference value and defined as 100. Individual fluorescence values obtained before and after incubation were normalised to this reference. Glucose uptake was then expressed as normalised fluorescence relative to baseline (baseline = 100). Fluorescence microscopy and image analysis Fluorescence imaging was performed using a Live Cell Observer system (Carl Zeiss) equipped with temperature control (37 °C). Time-lapse images were acquired using a 40× objective and appropriate filter sets. Exposure time and acquisition parameters were kept constant within each experiment. Image analysis was conducted using ZEN software (Carl Zeiss). For each cell or fibre, fluorescence intensity was quantified by ROI analysis with background subtraction. When required, fluorescence values were normalised to baseline values to allow comparison between experimental conditions. Statistical analysis Data are presented as bar graphs, with individual data points shown as dots to illustrate data dispersion. Bars represent the mean ± standard error of the mean (SEM). Data distribution was assessed before statistical analysis. As the data did not follow a normal distribution, comparisons among experimental groups were performed using the Kruskal–Wallis test followed by Bonferroni-adjusted pairwise comparisons. Statistical significance was set at P < 0.05. The meaning of n is specified in each figure legend according to the experimental approach used. For immunoblot analyses shown in Figures 1 and 2, each bar represents an individual immunoblot determination/lane and no statistical analysis was performed. For GLUT4 translocation analysis in Figure 3, each data point represents an individual C2C12 myotube. For 6-NBDG uptake analysis in Figure 5, each data point represents an individual isolated FDB skeletal muscle fibre, and statistical comparisons were performed on normalised 6-NBDG fluorescence values, with baseline fluorescence defined as 100. Animals were used as the source of mature skeletal muscle fibres and were not assigned to treatment groups; treatments were applied ex vivo after fibre isolation and plating. Individual fibres were therefore considered observational units for fluorescence analysis, and the data are interpreted as single-fibre-level responses. AMPK phosphorylation in C2C12 myotubes under different experimental conditions. Fluorescent immunoblot analysis showing the phosphorylation level of AMPK in C2C12 myotubes exposed to different treatments. Representative immunoblots are shown together with the corresponding densitometric quantification of AMPK phosphorylation. Micrographs displayed above each lane correspond to the same cell cultures from which protein extracts were obtained for immunoblot analysis and illustrate the morphological appearance of the myotubes under the respective experimental conditions. (A) Control cells and cells treated with insulin (100 nM). (B) Cells treated with hydrogen peroxide (H₂O₂; 1, 10 and 100 μM). (C) Cells treated with nitric oxide donors SNAP and SNP (1 mM). (D) Cells treated with angiotensin II (2.5 and 10 μM). Each bar represents the phosphorylation value obtained from an individual immunoblot lane corresponding to the sample shown above. These values represent individual experimental determinations rather than averaged measurements. No statistical analysis was performed. AMPK phosphorylation levels were calculated as the ratio of phosphorylated AMPK to total AMPK following normalisation to actin (see Supplementary Figure S1 for quantification workflow). Additional images illustrating the morphology and viability of C2C12 myotubes under these experimental conditions are shown in the Supplementary Material. AKT phosphorylation in C2C12 myotubes under different experimental conditions. Fluorescent immunoblot analysis showing the phosphorylation level of AKT in C2C12 myotubes exposed to different treatments. Representative immunoblots are shown together with the corresponding densitometric quantification of AKT phosphorylation. Micrographs displayed above each lane correspond to the same cell cultures from which protein extracts were obtained for immunoblot analysis and illustrate the morphological appearance of the myotubes under the respective experimental conditions. (A) Control cells and cells treated with insulin (100 nM). (B) Cells treated with hydrogen peroxide (H₂O₂; 1, 10 and 100 μM). (C) Cells treated with nitric oxide donors SNAP and SNP (1 mM). (D) Cells treated with angiotensin II (2.5 and 10 μM). Each bar represents the phosphorylation value obtained from an individual immunoblot lane corresponding to the sample shown above. These values represent individual experimental determinations rather than averaged measurements. No statistical analysis was performed. AKT phosphorylation levels were calculated as the ratio of phosphorylated AKT to total AKT following normalisation to actin (see Supplementary Figure S1 for quantification workflow). Additional images illustrating the morphology and viability of C2C12 myotubes under these experimental conditions are provided in the Supplementary Material. Effects of different pro-oxidant treatments on GLUT4 translocation in C2C12 myotubes. C2C12 myotubes expressing GLUT4-7myc-GFP were treated with the indicated agents and GLUT4 translocation was quantified by immunocytochemistry as the ratio of surface GLUT4 (anti-c-Myc signal) to total cellular GLUT4 (GFP signal), as described in Supplementary Figure S2. (A) Control, insulin (100 nM), H₂O₂ (10 and 100 µM). (B) Control, insulin (100 nM), SNAP (1 mM) and SNP (1 mM). (C) Control, insulin (100 nM), diamide (100 µM). (D) Control, insulin (100 nM), angiotensin II (2.5 and 10 µM). Bars represent mean ± SEM and dots represent individual C2C12 myotubes analysed for GLUT4 translocation. Mean values and sample size (n, number of myotubes analysed) are shown inside the bars. All data shown in Figure 3 were analysed together because the same control and insulin groups are shown across the different panels; the panels were separated only to improve visual clarity. Statistical significance was determined using the Kruskal–Wallis test followed by Bonferroni-adjusted pairwise comparisons (P < 0.05). Dashed connectors indicate statistically significant pairwise differences between the indicated groups. Analyses were conducted using IBM SPSS Statistics (version 30.0). Graphs were generated using GraphPad Prism (version 10.3.1) and Microsoft PowerPoint (version 16.107.2). Results In our previous study, we demonstrated that oxidative eustress facilitates glucose uptake [29]. In the present study, we aimed to determine how this occurs, which signalling pathways are involved, and which types and levels of RONS, or degree of oxidation, regulate this process. First, we explored different experimental situations in the C2C12 myoblasts/myotubes model and analysed the activation of two key signalling pathways, AKT and AMPK, which are involved in glucose uptake through the translocation of GLUT4. In this exploratory study, using quantitative immunoblotting to determine the phosphorylation of both AKT and AMPK, we observed that exposure of C2C12 myoblasts/myotubes to insulin (100 nM) for 1 hour did not affect AMPK phosphorylation (Figure 1A). However, the same treatment with insulin evoked AKT phosphorylation (Figure 2A). Treatment of C2C12 myoblasts/myotubes with H₂O₂ facilitated AMPK phosphorylation. This effect was more pronounced when cells were exposed to the higher H₂O₂ concentration, 100 μM (Figure 1B). In the case of AKT phosphorylation, the effect of H₂O₂ was clear at both low and high concentrations, 1 and 100 μM (Figure 2B). The effect of nitric oxide on the phosphorylation of AMPK and AKT appeared to be slightly different. Thus, exposure of C2C12 myoblasts/myotubes to nitric oxide donors, SNAP (1 mM) or SNP (1 mM), produced AMPK phosphorylation that was not different from that observed in untreated cells or in cells exposed to insulin (Figure 1C). In the case of AKT, we observed phosphorylation when myoblasts/myotubes were incubated with the nitric oxide donor SNAP and, although less evident, also when cells were treated with the nitric oxide donor SNP (Figure 2C). We then assessed another experimental condition, exposure of cells to angiotensin II, that has been proposed to evoke a certain degree of oxidation. Through binding to one of its receptors (AT1), angiotensin II may interact with NADPH oxidase 2 (NOX2), leading to the production of superoxide [2,21]. We treated myoblasts/myotubes with angiotensin II at two concentrations, 2.5 and 10 μM. The results showed that angiotensin II evoked AMPK phosphorylation, which was more evident at 2.5 μM than at the higher concentration, 10 μM (Figure 1D). A similar pattern was observed for AKT phosphorylation: angiotensin II at 2.5 μM induced more AKT phosphorylation than 10 μM angiotensin II (Figure 2D). We implemented quantitative immunocytochemistry to perform exploratory experiments aimed at evaluating GLUT4 translocation from cytosolic vesicles to the sarcolemma. This process increases the density of GLUT4 transporters at the cell surface, thereby increasing the capacity for glucose uptake. Experiments were carried out in myotubes expressing a GLUT4 reporter and quantified as described in Supplementary Figure S2. We observed that myotubes treated with insulin (100 nM) for 15 min showed slightly higher GLUT4 translocation compared with untreated myotubes. Myotubes treated with H₂O₂ showed increased GLUT4 translocation, with the strongest effect observed at 100 μM, which was significantly different from control cells (Figure 3A). This finding is consistent with the hypothesis that H₂O₂ contributes to GLUT4 translocation. To further explore whether other oxidant stimuli could produce similar effects, another group of myotubes was exposed to the oxidant reagent diamide (100 μM) for 15 min. The results showed that diamide was associated with a significant increase in GLUT4 translocation in these myotubes (Figure 3C). We also tested the effect of angiotensin II and observed that treatment with angiotensin II (2.5 or 10 μM for 15 min) increased GLUT4 translocation, although only the 2.5 μM concentration was significantly different from control cells (Figure 3D). Notably, the increase was more pronounced at 2.5 μM than at 10 μM. These results collectively suggest that oxidative redox signals may contribute to the regulation of GLUT4 translocation in myotubes. Finally, when myotubes were treated with nitric oxide donors, either SNAP or SNP (1 mM) for 15 min, GLUT4 translocation values were slightly higher than in untreated myotubes, although these differences were not statistically significant (Figure 3B). Figure 4 shows confocal fluorescence microscopy images that allow detailed visualisation of the localisation of the GLUT4 reporter in the cytosol and at the plasma membrane of myotubes. In these experiments, cells were not permeabilized prior to incubation with the anti-c-Myc antibody directed against the extracellular Myc epitope, allowing selective detection of surface-exposed GLUT4. Representative confocal images illustrating GLUT4 translocation detected by surface immunocytochemistry in C2C12 myotubes. C2C12 myotubes expressing GLUT4-7myc-GFP were fixed and processed for surface immunocytochemistry using an anti-c-Myc primary antibody (mouse monoclonal, Abcam [9E10], ab32, 1:200) and Alexa Fluor 568-conjugated secondary antibody (Invitrogen A11031, 1:1000). Cells were not permeabilized prior to incubation with the anti-Myc antibody directed against the extracellular Myc epitope, allowing selective detection of surface-exposed GLUT4. Green fluorescence corresponds to total cellular GLUT4 (GFP), red fluorescence indicates surface-exposed GLUT4 detected by anti-c-Myc immunostaining, and blue fluorescence corresponds to nuclear staining. Upper row (left to right): control, insulin (300 nM, 5 min), insulin (300 nM, 10 min). Lower row (left to right): H₂O₂ (100 µM), SNAP (1 mM), SNP (1 mM). These images correspond to qualitative experiments performed during the initial validation of the immunocytochemistry method used to detect GLUT4 translocation. The images illustrate that exposure of myotubes to the physiological hormone insulin, as well as to RONS such as H₂O₂ and nitric oxide donors, is associated with increased localisation of GLUT4 at the plasma membrane. This effect is evident as an increased presence of the GLUT4 reporter, detected as red-orange fluorescence, at the plasma membrane. In treated myotubes, the surface immunostaining produces a characteristic peripheral ‘halo-like’ fluorescence pattern outlining the myotube membrane, consistent with the localisation of GLUT4 at the cell surface (Figure 4). These qualitative observations are consistent with the quantitative analysis of GLUT4 translocation presented in Figure 3. The third important issue in our study was to evaluate whether RONS, more specifically oxidative eustress, might affect glucose uptake in skeletal muscle fibres isolated from the FDB mouse muscle. We used a methodology based on the fluorescent glucose analogue 6-NBDG, which we have recently developed and optimised [29]. Figure 5 shows the effect of different experimental conditions, including insulin and oxidant treatments, on 6-NBDG/glucose uptake in isolated skeletal muscle fibres. 6-NBDG glucose uptake in isolated FDB skeletal muscle fibres. Representative images of flexor digitorum brevis (FDB) muscle fibres isolated from C57BL/6J mice before (left) and after (right) 60 min incubation with the fluorescent glucose analogue 6-NBDG in the presence of the indicated treatments. The central graphs show fluorescence intensity measured in individual fibres before and after incubation with 6-NBDG, expressed in arbitrary units (a.u.). Increased fluorescence reflects intracellular accumulation of 6-NBDG and therefore glucose uptake. Each point represents an individual isolated FDB skeletal muscle fibre analysed for 6-NBDG fluorescence. Fibres were obtained from both FDB muscles isolated from 9 female C57BL/6J mice of the same age range and genetic background. Animals were used as the source of fibres and were not assigned to treatment groups; treatments were applied ex vivo after fibre isolation and plating. Individual fibres were considered observational units for fluorescence analysis. Fluorescence values were normalised to the mean baseline fluorescence measured before incubation, which was defined as 100. The bar graphs on the right show normalised 6-NBDG fluorescence (baseline = 100) for each treatment. Statistical significance was determined using the Kruskal–Wallis test followed by Bonferroni-adjusted pairwise comparisons (P < 0.05). Dashed connectors indicate statistically significant pairwise differences between the indicated groups. Treatments: (A) Control. (B) Insulin (300 nM). (C) Hydrogen peroxide (1 µM). (D) Hydrogen peroxide (10 µM). (E) Hydrogen peroxide (100 µM). (F) SNAP (1 mM). (G) SNP (1 mM). The images shown are representative and do not necessarily correspond to the same fibre used for quantification. Fibres were incubated with 6-NBDG in Krebs medium, which contains 11 mM glucose (thus without glucose deprivation). Uptake of 6-NBDG during 60 min was then determined. The results showed that 6-NBDG was internalised in untreated fibres, reaching a normalised fluorescence value of 174% relative to baseline after 60 min of incubation (Figure 5A). When fibres were treated with insulin, normalised 6-NBDG fluorescence increased to 350% of baseline (Figure 5B), showing a higher mean value than control fibres. However, this difference did not reach statistical significance compared with control after Bonferroni-adjusted non-parametric analysis. Exposure of fibres to H₂O₂ showed a clear increase in normalised fluorescence in a dose-dependent manner: H₂O₂ 1 μM, 225% (Figure 5C); H₂O₂ 10 μM, 435% (Figure 5D); and H₂O₂ 100 μM, 885% of baseline (Figure 5E). H₂O₂ 10 µM and 100 µM were significantly different from control, whereas H₂O₂ 1 µM produced a smaller increase that did not reach statistical significance. In addition, H₂O₂ 100 µM was significantly higher than H₂O₂ 1 µM. These results show that H₂O₂ exposure is associated with a concentration-dependent increase in glucose uptake. In other experiments, fibres were treated with nitric oxide donors in order to assess the effect of nitric oxide on glucose uptake. Treatment with 1 mM SNAP increased fluorescence to 205% of baseline (Figure 5F), whereas treatment with 1 mM SNP increased it to 501% of baseline (Figure 5G). SNP was significantly higher than both control and SNAP, whereas SNAP induced a more modest increase that did not reach statistical significance compared with control. These results suggest that nitric oxide donor exposure, particularly SNP, is associated with increased glucose uptake in skeletal muscle fibres. These findings are consistent with the increased GLUT4 translocation observed in Figure 3 and the corresponding membrane localisation shown in Figure 4, supporting a functional link between GLUT4 redistribution observed under redox-modulating conditions and glucose uptake. Discussion In a previous publication, it was reported that moderate levels of oxidation, or a pro-oxidative intracellular redox environment produced by reactive oxygen and nitrogen species, defined as oxidative eustress, facilitate glucose uptake in skeletal muscle cells [29]. In the present study, we aimed to investigate the mechanisms underlying this effect, focusing on two key signalling pathways involved in glucose uptake, AKT and AMPK. Activation of these pathways promotes the translocation of intracellular vesicles containing GLUT4 to the plasma membrane, increasing the density of GLUT4 at the cell surface and facilitating glucose internalisation [16,22,24]. Thus, the first objective of our study was to assess whether oxidative eustress favours the phosphorylation of AKT and AMPK. Using an immunoblotting-based approach, we quantified phosphorylation levels of both kinases. We acknowledge that this part of the study is exploratory and that additional experiments will be required to further strengthen these findings. It is well established that insulin is the main physiological factor facilitating glucose uptake through activation of the canonical AKT-dependent pathway [24]. In agreement with this, our results show that insulin treatment induces AKT phosphorylation (Figure 2A), whereas it did not affect AMPK phosphorylation (Figure 1A). This is consistent with previous reports indicating that glucose uptake mediated through AMPK activation is insulin-independent and typically associated with stimuli such as exercise or physical activity [12,13]. Hydrogen peroxide treatment was associated with increased AMPK (Figure 1B) and AKT phosphorylation (Figure 2B), suggesting that hydrogen peroxide may modulate key signalling pathways involved in the regulation of glucose uptake in skeletal muscle [4,6,30]. These effects were observed at concentrations ranging from 1 to 100 μM. However, particularly for 100 μM H₂O₂, these conditions should be interpreted as redox-modulating experimental conditions rather than as direct physiological intracellular H₂O₂ concentrations. No evident morphological signs of cellular damage were observed under these conditions (Supplementary Figure S4). To assess the effect of nitric oxide, C2C12 myoblasts/myotubes were incubated with the nitric oxide donors SNAP and SNP. AMPK phosphorylation showed variability, with relatively high basal levels in control cells. Although phosphorylation was detected following SNAP and SNP treatment, it was lower than in controls. In contrast, some samples treated with nitric oxide donors exhibited increased AKT phosphorylation compared with controls (Figure 2C). Considering the semi-quantitative nature of these data and the limited number of samples analysed, these findings suggest that nitric oxide may induce a modest activation of AKT under these conditions. These observations are consistent with the role of nitric oxide as a redox signalling molecule that regulates cellular function through post-translational modifications such as S-nitrosylation [10,11]. Importantly, no evident morphological signs of cellular damage were observed, indicating that nitric oxide levels were likely within a non-damaging, eustress range (Supplementary Figure S4). Angiotensin II has been reported to activate NADPH oxidase, leading to increased ROS production [2,31]. We therefore explored whether angiotensin II–derived ROS could influence AKT and AMPK activation. Treatment with angiotensin II (2.5 or 10 μM) induced phosphorylation of both kinases, with a more pronounced effect at 2.5 μM (Figure 1D and 2D). No evident morphological signs of cellular damage were observed at either concentration (Supplementary Figure S4), suggesting that angiotensin II exposure generated a redox condition compatible with oxidative eustress and associated with AKT and AMPK activation, which may contribute to the regulation of glucose uptake. To further explore the downstream consequences of oxidative eustress, we assessed GLUT4 translocation to the plasma membrane. We developed and optimised a quantitative immunocytochemistry approach combined with imaging analysis in C2C12 myotubes to evaluate GLUT4 localisation. The presence of GLUT4 at the plasma membrane reflects the translocation of intracellular GLUT4-containing vesicles, a process regulated, among other factors, by activation of AKT and AMPK signalling pathways [16,18,32]. Exposure of C2C12 myoblasts/myotubes to hydrogen peroxide was associated with increased GLUT4 presence at the plasma membrane, with the 100 μM concentration reaching statistical significance compared with control cells (Figure 3A). These findings support the hypothesis that hydrogen peroxide, under non-damaging oxidative eustress conditions, enhances GLUT4 translocation. Although insulin is the main physiological stimulus for GLUT4 translocation [16], in our experimental conditions, insulin induced only a modest increase compared with control cells (Figure 3A). This response should be interpreted with caution, as C2C12 myotubes are less mature than adult post-mitotic skeletal muscle fibres and may not fully reproduce the abundance, distribution or functional coupling of the insulin receptor/PI3K/AKT/GLUT4 signalling axis present in mature fibres. Moreover, GLUT4 translocation was assessed in C2C12 myotubes after 15 min of insulin stimulation, whereas insulin-induced glucose uptake was evaluated functionally in isolated FDB fibres after 60 min. These differences in model, endpoint and stimulation time may explain why insulin produced a modest GLUT4 translocation response in C2C12 myotubes, whereas isolated skeletal muscle fibres showed increased 6-NBDG uptake relative to baseline, although this response was not significantly different from control after Bonferroni-adjusted non-parametric analysis. Similarly, exposure to nitric oxide donors resulted in GLUT4 levels comparable to those observed with insulin and slightly higher than controls, although these differences were not statistically significant (Figure 3B). The nitric oxide donor treatments used were associated with preserved cell morphology, as no evident morphological signs of cellular damage were observed under these conditions (Supplementary Figure S4), consistent with our previous work [8]. The effects of nitric oxide donors should be interpreted in the context of the different experimental models used. SNAP and SNP induced only modest, non-significant increases in GLUT4 translocation in C2C12 myotubes, whereas nitric oxide donor exposure, particularly SNP, was associated with increased 6-NBDG uptake in isolated FDB fibres. The different behaviour observed in these two assays may reflect differences between experimental models and endpoints, including C2C12 myotubes versus mature skeletal muscle fibres, and GLUT4 surface redistribution after 15 min versus 6-NBDG accumulation after 60 min. In addition, nitric oxide donor-induced glucose uptake may involve mechanisms not exclusively dependent on detectable GLUT4 translocation in the C2C12 assay, including GLUT4-independent transport pathways such as GLUT1-mediated basal glucose transport, redox-dependent modulation of transporter activity or changes in intracellular glucose handling. Further studies assessing GLUT1 and GLUT4 trafficking directly in mature fibres, together with transporter-specific inhibition, would help define these mechanisms. We also evaluated the effect of the oxidant reagent diamide, which promotes oxidation of reduced glutathione (GSH) to oxidised glutathione (GSSG), thereby inducing an oxidative intracellular environment [33,34]. Exposure of C2C12 myoblasts/myotubes to diamide (100 μM, 15 min) resulted in a marked increase in GLUT4 translocation to the plasma membrane (Figure 3C), without affecting cell morphology. These results indicate that oxidative eustress induced by diamide enhances GLUT4 translocation. Angiotensin II treatment was also associated with increased GLUT4 translocation in C2C12 myoblasts/myotubes. Exposure to 2.5 μM angiotensin II was associated with a pronounced increase in GLUT4 translocation, whereas a higher concentration (10 μM) produced a smaller effect that was not significantly different from control (Figure 3D). These findings are consistent with a non-linear, concentration-dependent redox response and support an association between angiotensin II–induced redox signalling, compatible with oxidative eustress, and increased GLUT4 translocation. Using confocal fluorescence microscopy as a qualitative approach, we further confirmed these observations in C2C12 myoblasts/myotubes expressing a GLUT4 reporter. Insulin, hydrogen peroxide (100 μM), and nitric oxide donors all increased GLUT4 presence at the plasma membrane, with nitric oxide effects being more evident for SNP than SNAP (Figure 4). These observations are consistent with the concept that moderate levels of reactive oxygen and nitrogen species are associated with increased GLUT4 localisation at the cell surface. Finally, we evaluated whether oxidative eustress affects glucose uptake at a functional level using isolated skeletal muscle fibres and the fluorescent glucose analogue 6-NBDG. Insulin treatment increased intracellular 6-NBDG fluorescence relative to baseline, although the difference compared with control did not reach statistical significance after Bonferroni-adjusted non-parametric analysis. Hydrogen peroxide exposure was associated with a concentration-dependent increase in glucose uptake, with significant effects observed at 10 and 100 µM, while nitric oxide donors, particularly SNP, also increased glucose uptake (Figure 5). Although 100 µM H₂O₂ produced the largest increase in 6-NBDG uptake, this concentration should be interpreted as a higher extracellular redox-modulating condition, likely close to the upper boundary of the oxidative eustress range under our experimental conditions, rather than as a direct estimate of intracellular H₂O₂ concentration. The effective intracellular H₂O₂ signal generated by extracellular H₂O₂ depends on diffusion, membrane permeability and transport, including aquaporins, as well as on enzymatic and non-enzymatic antioxidant systems. Therefore, the magnitude of the response observed at 100 µM H₂O₂ requires cautious interpretation and further investigation using genetically encoded H₂O₂ biosensors. Importantly, these functional changes are consistent with the increased GLUT4 translocation and membrane localisation observed in Figures 3 and 4, supporting a functional link between GLUT4 redistribution observed under redox-modulating conditions and glucose uptake. Taken together, our results indicate that oxidative eustress induced by hydrogen peroxide, nitric oxide and angiotensin II is associated with activation of AKT and AMPK signalling, increased GLUT4 translocation and enhanced glucose uptake in skeletal muscle cells and fibres. These findings support a physiological role for redox signalling in the regulation of skeletal muscle glucose metabolism and are consistent with previous reports demonstrating that glucose uptake in skeletal muscle can be regulated by both insulin-dependent and insulin-independent mechanisms [12,13]. The combined use of C2C12 myoblasts/myotubes and isolated mature FDB skeletal muscle fibres represents a relevant methodological feature of the present study. C2C12 cells provide a well-established and experimentally tractable model to analyse redox-associated signalling events and GLUT4 translocation under controlled conditions. In parallel, isolated FDB fibres provide a physiologically relevant ex vivo preparation to assess functional glucose uptake in mature, post-mitotic skeletal muscle fibres that were differentiated in their natural in vivo niche rather than through an in vitro differentiation process. This approach provides a useful experimental basis for future studies using primary and human skeletal muscle models to validate and extend these findings in more translational contexts. In this study, GLUT4 translocation was assessed in C2C12 myotubes, whereas functional glucose uptake was measured in isolated mature FDB fibres. Therefore, although these complementary approaches support a functional association between GLUT4 redistribution and glucose uptake, the present study does not directly demonstrate GLUT4 translocation in isolated skeletal muscle fibres. Future studies will be required to determine whether redox-modulating conditions also regulate GLUT4 trafficking directly in mature fibres, including in insulin-resistant models such as high-fat diet-fed mice. Despite the consistency of our findings, several limitations should be acknowledged. The analysis of AKT and AMPK phosphorylation was exploratory and based on a limited number of samples, and additional studies will be required to confirm these observations. Although our results show that redox stimulation is associated with AKT and AMPK phosphorylation, GLUT4 translocation and increased glucose uptake, the present study does not demonstrate that AKT or AMPK are required mediators of these effects. Future studies using pharmacological inhibition, gene silencing or combined loss-of-function approaches will be necessary to establish causality and to define the precise contribution of each signalling pathway to redox-regulated GLUT4 trafficking and glucose uptake. In addition, studies using selective pharmacological inhibitors of GLUT4, together with analysis of GLUT1 and GLUT4 trafficking directly in mature fibres, would clarify the relative contribution of GLUT4-dependent and GLUT4-independent transport mechanisms to redox-associated glucose uptake. Another limitation of the present study is that intracellular H₂O₂, nitric oxide levels and redox state were not directly quantified under each experimental condition. Therefore, although the treatments used were interpreted as redox-modulating conditions compatible with oxidative eustress, the precise spatiotemporal redox signals involved remain to be defined. In previous studies, we have used genetically encoded biosensors, including HyPer-based H₂O₂ biosensors and genetically encoded NO biosensors, together with quantitative fluorescence microscopy, to monitor intracellular redox dynamics in C2C12 myoblasts/myotubes and isolated skeletal muscle fibres [7,8]. Future studies using compartment-specific biosensors, including cytosolic and mitochondrial HyPer7, will be necessary to determine how defined H₂O₂ and NO signals are associated with AKT/AMPK phosphorylation, GLUT4 trafficking and glucose uptake. Future work should aim to define the spatiotemporal dynamics of reactive oxygen and nitrogen species and their specific molecular targets, as well as to further characterise GLUT4 trafficking and glucose uptake using more quantitative and dynamic approaches. Ca2+-dependent signalling pathways should also be considered in this context, as Ca2+ dynamics are closely linked to contractile activity, AMPK signalling and GLUT4 vesicle trafficking in skeletal muscle, and are sensitive to redox modulation. Future studies combining intracellular Ca2+ monitoring with genetically encoded redox biosensors and GLUT4 trafficking analysis would be useful to determine whether Ca2+-dependent mechanisms contribute to the effects of low-level RONS on GLUT4 translocation and glucose uptake. It will also be important to determine whether sex, age or metabolic status, including insulin-resistant conditions such as high-fat diet feeding, influence redox-associated GLUT4 trafficking and glucose uptake in skeletal muscle. From a translational perspective, modulation of redox signalling within an oxidative eustress range may represent a potential strategy to improve glucose handling in skeletal muscle and to target metabolic disorders associated with insulin resistance, including type 2 diabetes, obesity and ageing. Overall, these findings support oxidative eustress as a physiological mechanism linking redox signalling to metabolic regulation in skeletal muscle. Supplementary Material Supplementary Material ARRIVE_Guidelines_Checklist_Redox_Report_R2_editJP.pdf Supplementary Material Supplementary material_Redox Report 2026_R2_clean.docx